Frontiers in Pharmacology · 2019 · 48 citations · 24 references
Life SciencesCardiologyPharmacologyApoptosisCell SignalingSignal TransductionApoptosis ModulationApoptosis RegulationApoptotic Signal TransductionApoptotic SignalingCardiovascular Molecular PhysiologyNeuroprotectionAnti-apoptotic AgentsAnti-apoptotic BalanceBlood Glucose RegulationForkhead Box O SignalingForkhead Box Protein O1 RegulationForkhead Box ProteinsGlucose-lowering TherapyMyocardial Ischemia-reperfusion Injury
Cardiovascular complications are the most prevalent cause of morbidity and mortality in diabetic patients. Metformin is currently the first-line blood glucose-lowering agent with potential relevance to cardiovascular diseases. However, the underpinning mechanisms of action remain elusive. Here, we report that metformin represses cardiac apoptosis at least in part through inhibition of Forkhead box O1 (FoxO1) pathway. In a mouse model of ischemia-reperfusion (I/R), treatment with metformin attenuated cardiac and hypertrophic remodeling after 14 days of post-reperfusion. Additionally, cardiac expression of brain-like natriuretic peptide (BNP) was significantly reduced in metformin-treated mice after 14 days of cardiac I/R. In cultured H9C2 cells, metformin counteracted hypertrophic and apoptotic responses to metabolic or hypoxic stress. FoxO1 silencing by siRNA abolished anti-apoptotic effect of metformin under hypoxic stress in H9C2 cells. Taken together, these results suggest that metformin protects the heart against hypertrophic and apoptotic remodeling after myocardial infarction.
24
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel et al. · New England Journal of Medicine · 2008 · 7.8K citations · Full text
Diabetes and cardiovascular disease. The Framingham study
William B. Kannel · JAMA · 1979 · 4K citations
Medicine, Cardiology, Endocrinology +17